Split Creek Capital LLC’s AbbVie ABBV Stock Holding History

Split Creek Capital LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Hold	6,860	–	–	1.59%	10
2026 Q1	$1.49M	Buy	6,860 +500	+8%	+$111K	1.57%	11
2025 Q4	$1.45M	Buy	+6,360	New	+$1.45M	1.54%	12

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Split Creek Capital LLC's ABBV Position: Q2 2026 in Review

Split Creek Capital LLC held its AbbVie (ABBV) position steady in Q2 2026 at 6,860 shares worth $1.73M. The position accounts for 1.59% of the portfolio, ranked #10.

Split Creek Capital LLC first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,249 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Split Creek Capital LLC held 6,860 shares of AbbVie worth $1.73M as of Q2 2026.
Split Creek Capital LLC left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.59% of Split Creek Capital LLC's portfolio in Q2 2026, its #10 holding.
Split Creek Capital LLC first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
4,249 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Split Creek Capital LLC's 13F filing for Q2 2026, filed 23 Oct 2026.